U.K.-based Ultromics announced it received FDA Breakthrough Device Designation for an AI tool that aims to detect cardiac amyloidosis.
The platform, called EchoGo Amyloidosis, analyzes echocardiograms to find signs of the condition, where the protein amyloid builds up in the heart and limits function. Though the designation isn’t a marketing approval from the FDA, it aims to accelerate review of...
Eyenuk received $25 million in Series A funding to expand access to its AI-powered eye-screening technology that enables autonomous detection of diabetic retinopathy (DR) during a patient's regular exam.
The recent raise was led by AXA IM Alts and joined by new and existing investors, including A&C Foelsgaard Alternativer ApS, T&W Medical A/S, KOFA Healthcare and Kendall Capital Partners...
AI-enabled diagnostics company Digital Diagnostics announced Tuesday it had raised $75 million in a Series B funding round led by KKR.
Other participants in the raise include Cedar Pine, Kinderhook, 8VC, Optum Ventures, OSF Ventures, Gundersen Health System, Edward-Elmhurst Health Venture Capital and the University of Iowa.
The company, previously known as IDx, said the Series B brings its total...
CUHK, ConsenSys launch COVID-19 Passport System
The Chinese University of Hong Kong (CUHK) and Ethereum software company ConsenSys have launched a health passport platform that runs on blockchain technology.
According to a press release, the Medoxie COVID-19 Digital Health Passport platform records test results, temperature checks and vaccinations in a "decentralised, private, and secure...
Autonomous AI platform Digital Diagnostics, previously known as IDx, announced that it has purchased 3Derm Systems in a move that would expand its reach into the dermatology space.
Digital Diagnostics got its start as an AI tool for diabetic retinopathy, but it’s now looking to expand its specialties. That is where the company is making bets on 3Derm.
Boston-based 3Derm specializes in providing...
